PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ AGONIST ATTENUATES ALCOHOL-INDUCED HEPATIC INSULIN RESISTANCE AND IMPROVES LIVER INJURY AND REPAIR

被引：0
|
作者：
Pang, Maoyin [1 ,2 ]
de la Monte, Suzanne [1 ,3 ]
He, Jiman [1 ,2 ]
Chaudhry, Rajeeve [1 ,2 ]
Duan, Kevin [1 ,2 ]
Ouh, Jiyun [1 ,2 ]
Wands, Jack R. [1 ,2 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Rhode Isl Hosp, Dept Med, Liver Res Ctr, Providence, RI 02903 USA
[3] Rhode Isl Hosp, Dept Pathol & Med, Providence, RI USA
来源：
HEPATOLOGY | 2008年 / 48卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
335
引用
收藏
页码：460A / 460A
页数：1
相关论文
共 50 条
  • [21] Peroxisome Proliferator-Activated Receptor Gamma Activation With Pioglitazone Attenuates Alcohol-Induced Human Alveolar Macrophage Oxidative Stress And Dysfunction
    Yeligar, S. M.
    Mehta, A. J.
    Brown, L.
    Hart, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [22] Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
    Schuster, Herbert
    Fagerberg, Bjorn
    Edwards, Sion
    Halmos, Tamas
    Lopatynski, Jerzy
    Stender, Steen
    Birketvedt, Grethe Stoa
    Tonstad, Serena
    Gause-Nilsson, Ingrid
    Halldorsdottir, Sigrun
    Oehman, K. Peter
    ATHEROSCLEROSIS, 2008, 197 (01) : 355 - 362
  • [23] Pharmacological Activation of Peroxisome Proliferator-activated Receptor δ Improves Insulin Resistance and Hepatic Steatosis in High Fat Diet-induced Diabetic Mice
    Wu, H. -T.
    Chen, C. -T.
    Cheng, K. -C.
    Li, Y. -X.
    Yeh, C. -H.
    Cheng, J. -T.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (09) : 631 - 635
  • [24] Muraglitazar - A dual peroxisome proliferator-activated receptor agonist
    Kirwin, J
    Van Amburgh, J
    FORMULARY, 2005, 40 (09) : 285 - +
  • [25] Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
    Cariou, Bertrand
    Hanf, Remy
    Lambert-Porcheron, Stephanie
    Zair, Yassine
    Sauvinet, Valerie
    Noel, Benoit
    Flet, Laurent
    Vidal, Hubert
    Staels, Bart
    Laville, Martine
    DIABETES CARE, 2013, 36 (10) : 2923 - 2930
  • [26] Liver X receptor and peroxisome proliferator-activated receptor agonist from Cornus alternifolia
    He, Yang-Qing
    Ma, Guo-Yi
    Peng, Jiang-nan
    Ma, Zhan-Ying
    Hamann, Mark T.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (07): : 1021 - 1026
  • [27] Peroxisome proliferator-activated receptor-α regulates postischemic liver injury
    Okaya, T
    Lentsch, AB
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2004, 286 (04): : G606 - G612
  • [28] Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischernia/reperfusion injury in a rat model
    Ito, H
    Nakano, A
    Kinoshita, M
    Matsumori, A
    LABORATORY INVESTIGATION, 2003, 83 (12) : 1715 - 1721
  • [29] Telmisartan Improves Insulin Resistance of Skeletal Muscle Through Peroxisome Proliferator-Activated Receptor-δ Activation
    Li, Li
    Luo, Zhidan
    Yu, Hao
    Feng, Xiaoli
    Wang, Peijian
    Chen, Jian
    Pu, Yunfei
    Zhao, Yu
    He, Hongbo
    Zhong, Jian
    Liu, Daoyan
    Zhu, Zhiming
    DIABETES, 2013, 62 (03) : 762 - 774
  • [30] Impact of oxidative stress and peroxisome proliferator-activated receptor γ coactivator-1α in hepatic insulin resistance
    Kumashiro, Naoki
    Tamura, Yoshifumi
    Uchida, Toyoyoshi
    Ogihara, Takeshi
    Fujitani, Yoshio
    Hirose, Takahisa
    Mochizuki, Hideki
    Kawamori, Ryuzo
    Watada, Hirotaka
    DIABETES, 2008, 57 (08) : 2083 - 2091
12345